Caspofungin Fresenius Kabi 70 mg powder for concentrate for solution for infusion
- Licence status
- Withdrawn: 21/01/2025
- Active substances
- Caspofungin
- Dosage Form
- Powder for concentrate for solution for infusion
- Licence number
- PA2059/005/002
- Licence holder
- Fresenius Kabi Deutschland GmbH
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- J02AX Other antimycotics for systemic use, J02AX04 caspofungin
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 02/12/2016